Effects of immune complex formation and complement activation on circulating platelets in the primate.
暂无分享,去创建一个
D. Birmingham | L. Hebert | P. Higgins | A. Creasey | X. P. Shen | C. G. Yeh | C. Yeh
[1] J. Köhl,et al. Site-directed C3a receptor antibodies from phage display libraries. , 1998, Journal of immunology.
[2] P. Higgins,et al. A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities. , 1997, Journal of immunology.
[3] D. Birmingham,et al. The baboon erythrocyte complement receptor is a glycophosphatidylinositol-linked protein encoded by a homologue of the human CR1-like genetic element. , 1996, Journal of immunology.
[4] R. Quigg,et al. Characterization of rat complement receptors and regulatory proteins. CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1. , 1995, Journal of immunology.
[5] W. Couser,et al. The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis. , 1995, Journal of the American Society of Nephrology : JASN.
[6] F. Cosio,et al. Effect of chronically increased erythrocyte complement receptors on immune complex nephritis. , 1994, Kidney international.
[7] F. Cosio,et al. Platelet involvement in experimental immune complex-mediated glomerulonephritis in the nonhuman primate. , 1993, Kidney international.
[8] P. Sims,et al. The response of human platelets to activated components of the complement system. , 1991, Immunology today.
[9] C. Alpers,et al. Platelet-complement interactions in mesangial proliferative nephritis in the rat. , 1991, The American journal of pathology.
[10] F. Cosio,et al. Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates. , 1990, The Journal of laboratory and clinical medicine.
[11] J. Koudstaal,et al. Intraglomerular platelet aggregation and experimental glomerulonephritis. , 1990, Kidney international.
[12] C. Alpers,et al. Mechanisms and kinetics for platelet and neutrophil localization in immune complex nephritis. , 1989, Kidney international.
[13] M. Casaretto,et al. Characterization of C3a receptor‐proteins on guinea pig platelets and human polymorphonuclear leukocytes , 1989, European journal of immunology.
[14] F. Vivanco,et al. Role of complement-derived peptides in thrombocytopenia elicited by soluble aggregates of immunoglobulin G in the rat. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[15] K. Yancey,et al. Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies. , 1989, The Journal of investigative dermatology.
[16] C. Alpers,et al. Platelets mediate neutrophil-dependent immune complex nephritis in the rat. , 1988, The Journal of clinical investigation.
[17] D. Mendrick,et al. Determinants of immune complex-mediated glomerulonephritis. , 1988, Kidney international.
[18] T. Hugli,et al. Demonstration of a specific C3a receptor on guinea pig platelets. , 1988, Journal of immunology.
[19] J. Atkinson,et al. Identification of a C3b/iC3 binding protein of rabbit platelets and leukocytes. A CR1-like candidate for the immune adherence receptor. , 1988, Journal of immunology.
[20] L. Cosgrove,et al. CR3 receptor on platelets and its role in the prostaglandin metabolic pathway , 1987, Immunology and cell biology.
[21] D. Fearon,et al. Cellular distribution of complement receptor type 4 (CR4): expression on human platelets. , 1987, Journal of immunology.
[22] C. Anderson,et al. Human platelet Fc receptor for immunoglobulin G. Identification as a 40,000-molecular-weight membrane protein shared by monocytes. , 1985, The Journal of clinical investigation.
[23] M. Polley,et al. Human platelet activation by C3a and C3a des-arg , 1983, The Journal of experimental medicine.
[24] P. Ward,et al. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. , 1982, The Journal of clinical investigation.
[25] H. Jacob,et al. Complement-induced granulocyte aggregation in vivo. , 1981, The American journal of pathology.
[26] D. Bitter‐Suermann,et al. Platelet-serotonin release by C3a and C5a: two independent pathways of activation. , 1981, Journal of immunology.
[27] P. Naish,et al. Quantitative assessment of the effects of platelet depletion in the autologous phase of nephrotoxic serum nephritis. , 1979, Clinical and experimental immunology.
[28] D. Birmingham. Erythrocyte complement receptors. , 1995, Critical reviews in immunology.
[29] R. Frade,et al. Activation of human platelets through gp140, the C3d/EBV receptor (CR2) , 1987, European journal of immunology.